• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

丹参酮 II-A 可减轻肾血管性高血压大鼠的心肌纤维化并调节胶原代谢。

Tanshinone II-A attenuates cardiac fibrosis and modulates collagen metabolism in rats with renovascular hypertension.

机构信息

Department of Pharmacology and Toxicology, School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou, PR China.

出版信息

Phytomedicine. 2010 Dec 15;18(1):58-64. doi: 10.1016/j.phymed.2010.06.002. Epub 2010 Jul 16.

DOI:10.1016/j.phymed.2010.06.002
PMID:20638255
Abstract

The adaptive changes that develop in the pressure-overloaded left ventricular myocardium include cardiac hypertrophy and interstitial fibrosis. The objectives of the present study were to evaluate the effects of Tanshinone II-A, a bioactive diterpene quinone isolated from Danshen, on cardiac fibrosis and collagen metabolism in rats with renovascular hypertension. Male Sprague-Dawley rats were subjected to two-kidney two-clip (2K2C) or sham operation (sham) and treated with Valsartan (Val, 26.7 mg/kg/d), Tanshinone II-A (Tsn, 70, 35 mg/kg/d) or vehicle. Six weeks later, systolic blood pressure (BP), LV weight, collagen abundance, cardiac function parameters, hydroxyproline content and mRNA levels of matrix metalloproteinase (MMP)-2, MMP-9, tissue inhibitor of metalloproteinase (TIMP)-1 and TIMP-2 were evaluated. Both high-dose (Tsn-H, 70 mg/kg/d) and low-dose (Tsn-L, 35 mg/kg/d) of Tsn failed to attenuate 2K2C-induced BP elevation but significantly attenuated the attendant interstitial fibrosis. Val suppressed elevations of BP and left ventricular systolic pressure (LVSP) in 2K2C rats. Val and Tsn-H exerted comparable suppressive effects on the gene expression of MMP-9 and TIMP-1, while Val decreased the MMP-2 mRNA level without affecting the transcript levels of TIMP-2. Both Val and Tsn-H attenuated cardiac dysfunction, while Tsn-L showed slight improvement. These data demonstrate for the first time, that Tsn prevented cardiac fibrosis and improved cardiac function in a rat model of renovascular hypertensive independent of hypotensive effect. Tsn conferred its beneficial effects on the collagen metabolism probably through its regulation of transcript levels of the MMPs/TIMPs balance.

摘要

压力超负荷引起的左心室心肌适应性改变包括心肌肥厚和间质纤维化。本研究的目的是评价丹参酮 IIA(丹参中的一种生物活性二萜醌)对两肾两夹型高血压大鼠心肌纤维化和胶原代谢的影响。雄性 Sprague-Dawley 大鼠接受两肾两夹(2K2C)或假手术(假手术),并给予缬沙坦(Val,26.7mg/kg/d)、丹参酮 IIA(Tsn,70、35mg/kg/d)或载体处理。6 周后,评估收缩压(BP)、LV 重量、胶原含量、心功能参数、羟脯氨酸含量以及基质金属蛋白酶(MMP)-2、MMP-9、金属蛋白酶组织抑制剂(TIMP)-1 和 TIMP-2 的 mRNA 水平。高剂量(Tsn-H,70mg/kg/d)和低剂量(Tsn-L,35mg/kg/d)的 Tsn 均不能减轻 2K2C 引起的血压升高,但明显减轻了伴随的间质纤维化。Val 抑制 2K2C 大鼠的血压和左心室收缩压(LVSP)升高。Val 和 Tsn-H 对 MMP-9 和 TIMP-1 的基因表达具有相似的抑制作用,而 Val 降低了 MMP-2 的 mRNA 水平,而不影响 TIMP-2 的转录水平。Val 和 Tsn-H 均改善了心功能障碍,而 Tsn-L 仅略有改善。这些数据首次表明,Tsn 可预防压力超负荷大鼠的心肌纤维化并改善心功能,而与降压作用无关。Tsn 通过调节 MMPs/TIMPs 平衡的转录水平对胶原代谢产生有益作用。

相似文献

1
Tanshinone II-A attenuates cardiac fibrosis and modulates collagen metabolism in rats with renovascular hypertension.丹参酮 II-A 可减轻肾血管性高血压大鼠的心肌纤维化并调节胶原代谢。
Phytomedicine. 2010 Dec 15;18(1):58-64. doi: 10.1016/j.phymed.2010.06.002. Epub 2010 Jul 16.
2
Fosinopril and valsartan intervention in gene expression of Klotho, MMP-9, TIMP-1, and PAI-1 in the kidney of spontaneously hypertensive rats.福辛普利和缬沙坦对自发性高血压大鼠肾脏中Klotho、基质金属蛋白酶-9、金属蛋白酶组织抑制因子-1和纤溶酶原激活物抑制剂-1基因表达的干预作用
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2010 Oct;35(10):1048-56. doi: 10.3969/j.issn.1672-7347.2010.10.004.
3
Contribution of different Nox homologues to cardiac remodeling in two-kidney two-clip renovascular hypertensive rats: effect of valsartan.不同Nox同源物对两肾两夹肾血管性高血压大鼠心脏重塑的作用:缬沙坦的影响
Pharmacol Res. 2007 May;55(5):408-17. doi: 10.1016/j.phrs.2007.01.016. Epub 2007 Feb 2.
4
Increased cardiac expression of tissue inhibitor of metalloproteinase-1 and tissue inhibitor of metalloproteinase-2 is related to cardiac fibrosis and dysfunction in the chronic pressure-overloaded human heart.金属蛋白酶组织抑制因子-1和金属蛋白酶组织抑制因子-2在心脏中的表达增加与慢性压力超负荷人类心脏的心肌纤维化及功能障碍相关。
Circulation. 2005 Aug 23;112(8):1136-44. doi: 10.1161/CIRCULATIONAHA.104.516963. Epub 2005 Aug 15.
5
Reduced MMP-2 activity contributes to cardiac fibrosis in experimental diabetic cardiomyopathy.基质金属蛋白酶-2(MMP-2)活性降低促成实验性糖尿病心肌病中的心脏纤维化。
Basic Res Cardiol. 2008 Jul;103(4):319-27. doi: 10.1007/s00395-008-0715-2. Epub 2008 Mar 17.
6
Temporal changes in cardiac matrix metalloproteinase activity, oxidative stress, and TGF-β in renovascular hypertension-induced cardiac hypertrophy.血管性高血压引起的心脏肥厚中心脏基质金属蛋白酶活性、氧化应激和 TGF-β 的时变。
Exp Mol Pathol. 2013 Feb;94(1):1-9. doi: 10.1016/j.yexmp.2012.10.010. Epub 2012 Oct 13.
7
[Role of valsartan on myocardial Calpain I, calcineurin and Ca/calmodulin-dependent protein kinase IIδ expression of renovascular hypertensive rats].缬沙坦对肾血管性高血压大鼠心肌钙蛋白酶I、钙调神经磷酸酶及钙/钙调蛋白依赖性蛋白激酶IIδ表达的作用
Zhonghua Xin Xue Guan Bing Za Zhi. 2012 Jun;40(6):511-5.
8
[Effects of salviandic acid B (SA-B) on activity of basement membrane-type collagenase and impact of regulatory factors in rats with cardiac hypertrophy].丹酚酸B(SA-B)对心肌肥厚大鼠基底膜型胶原酶活性及调控因子的影响
Zhongguo Zhong Yao Za Zhi. 2011 Sep;36(17):2388-92.
9
[Mechanism of tanshinone II A inhibiting myocardial remodeling by Galectin-3].丹参酮IIA通过半乳糖凝集素-3抑制心肌重构的机制
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2022 Jun;34(6):640-645. doi: 10.3760/cma.j.cn121430-20220309-00232.
10
Chronic administration of hexarelin attenuates cardiac fibrosis in the spontaneously hypertensive rat.慢性给予 hexarelin 可减轻自发性高血压大鼠的心脏纤维化。
Am J Physiol Heart Circ Physiol. 2012 Sep 15;303(6):H703-11. doi: 10.1152/ajpheart.00257.2011. Epub 2012 Jul 27.

引用本文的文献

1
Harnessing the therapeutic value of Tanshinone IIA: a breakthrough therapy in cardiovascular diseases.利用丹参酮IIA的治疗价值:心血管疾病的突破性疗法。
Front Pharmacol. 2025 Jul 4;16:1620152. doi: 10.3389/fphar.2025.1620152. eCollection 2025.
2
The role of Chinese herbal medicine in the regulation of oxidative stress in treating hypertension: from therapeutics to mechanisms.中药在治疗高血压中调节氧化应激的作用:从治疗方法到作用机制
Chin Med. 2024 Oct 29;19(1):150. doi: 10.1186/s13020-024-01022-9.
3
Unveiling the Mechanism of Protective Effects of Tanshinone as a New Fighter Against Cardiovascular Diseases: A Systematic Review.
揭示丹参酮作为心血管疾病新斗士的保护作用机制:系统评价。
Cardiovasc Toxicol. 2024 Dec;24(12):1467-1509. doi: 10.1007/s12012-024-09921-x. Epub 2024 Sep 22.
4
A Comprehensive Review of Cardiovascular Disease Management: Cardiac Biomarkers, Imaging Modalities, Pharmacotherapy, Surgical Interventions, and Herbal Remedies.心血管疾病管理的综合述评:心脏生物标志物、成像方式、药物治疗、手术干预和草药疗法。
Cells. 2024 Sep 1;13(17):1471. doi: 10.3390/cells13171471.
5
Fufang Xueshuantong Improves Diabetic Cardiomyopathy by Regulating the Wnt/-Catenin Pathway.复方血栓通通过调控Wnt/β-连环蛋白信号通路改善糖尿病心肌病
Int J Endocrinol. 2022 Sep 19;2022:3919161. doi: 10.1155/2022/3919161. eCollection 2022.
6
in thorax and abdomainal organ fibrosis: A review of its pharmacology.在胸部和腹部器官纤维化方面:其药理学综述
Front Pharmacol. 2022 Sep 20;13:999604. doi: 10.3389/fphar.2022.999604. eCollection 2022.
7
Morphological and Functional Characteristics of Animal Models of Myocardial Fibrosis Induced by Pressure Overload.压力超负荷诱导的心肌纤维化动物模型的形态学和功能特征
Int J Hypertens. 2020 Jan 31;2020:3014693. doi: 10.1155/2020/3014693. eCollection 2020.
8
Salvia miltiorrhizaBurge (Danshen): a golden herbal medicine in cardiovascular therapeutics.丹参(Salvia miltiorrhizaBurge):心血管治疗中的金色草药。
Acta Pharmacol Sin. 2018 May;39(5):802-824. doi: 10.1038/aps.2017.193. Epub 2018 Apr 26.
9
Xyloketal B exerts antihypertensive effect in renovascular hypertensive rats via the NO-sGC-cGMP pathway and calcium signaling.木榴醇 B 通过 NO-sGC-cGMP 通路和钙信号发挥降压作用在肾血管性高血压大鼠。
Acta Pharmacol Sin. 2018 May;39(5):875-884. doi: 10.1038/aps.2018.12. Epub 2018 Mar 29.
10
Arjunolic acid, a peroxisome proliferator-activated receptor α agonist, regresses cardiac fibrosis by inhibiting non-canonical TGF-β signaling.阿朱诺酸,一种过氧化物酶体增殖物激活受体α激动剂,通过抑制非经典转化生长因子-β信号通路来减轻心脏纤维化。
J Biol Chem. 2017 Oct 6;292(40):16440-16462. doi: 10.1074/jbc.M117.788299. Epub 2017 Aug 18.